Mont-Saint-Guibert, Belgium - Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company plans to participate at the following conferences in September 2021:
2021 Wells Fargo Virtual Healthcare Conference
Dates: Thursday, September 9 - Friday, September 10, 2021
Presentation date: Thursday, September 9
Time: 11:20 a.m. ET / 05:20 p.m. CET
Presenter: Filippo Petti, CEO
A webcast link will be available on the Events section of the Celyad Oncologywebsite.
H.C. Wainwright 23rd Annual Global Investment Conference
Dates: Monday, September 13 - Wednesday, September 15, 2021
Presentation: On-demand starting September 13, 7 a.m. ET / 1 p.m. CET
Presenter: Filippo Petti, CEO
Baird's 2021 Virtual Global Healthcare Conference
Dates: Tuesday, September 14 - Wednesday, September 15, 2021
Presentation date: Tuesday, September 14
Time: 3:45 p.m. ET / 9:45 p.m. CET
Presenter: Filippo Petti, CEO
Attachments
- Original document
- Permalink
Disclaimer
Celyad Oncology SA published this content on 01 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 September 2021 05:11:05 UTC.